Related Experiment Videos
Radiolabelled mIBG in the treatment of neuroblastoma
1Meyerstein Institute of Oncology, Middlesex Hospital, London.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Technical Aspects of a National Service for Paediatric Pelvic Brachytherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
A Four-dimensional Computed Tomography Generated Internal Target Volume Approach to Paediatric High Risk Neuroblastoma to Reduce Organ at Risk and Normal Tissue Irradiation.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Permanent Indian ink tattoos for breast cancer radiotherapy: A United Kingdom study of the emotional impact on patients following radiotherapy.
Radiography (London, England : 1995)·2024
A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years.
Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Identifying Surrogates for Heart and Ipsilateral Lung Dose to Guide Field Placement and Treatment Modality Selection during Virtual Simulation of Breast Radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study.
European journal of cancer (Oxford, England : 1990)·2026
Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary?
European journal of cancer (Oxford, England : 1990)·2026
The UK's radiotherapy workforce shortage: Reforming regulation to address the gap.
European journal of cancer (Oxford, England : 1990)·2026
A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018).
European journal of cancer (Oxford, England : 1990)·2026
Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey.
European journal of cancer (Oxford, England : 1990)·2026
Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026